The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Open accessThe DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Abstract
Gut microbiota is emerging as a key regulator of many disease conditions and its dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal disorders. More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the possibility for new microbiota-based therapeutic options. Although several studies have been conducted to unravel the possible relationship between Alzheimer’s Disease (AD) pathogenesis and progression, the diagnostic and therapeutic potential of approaches aiming at restoring gut microbiota eubiosis remain to be fully addressed. In this narrative review, we briefly summarize the role of gut microbiota homeostasis in brain health and disease, and we present evidence for its dysregulation in AD patients. Based on these observations, we then discuss how dysbiosis might be exploited as a new diagnostic tool in early and advanced disease stages, and we examine the potential of prebiotics, probiotics, fecal microbiota transplantation, and diets as complementary therapeutic interventions on disease pathogenesis and progression, thus offering new insights into the diagnosis and treatment of this devastating and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following the successful use of FMT in the treatment of refractory or recurrent Clostridium difficile infection, several studies have been conducted to explore FMT as a therapeutic strategy for a wide range of neurological disorders, including multiple sclerosis, epilepsy, ASD, Tourette syndrome, diabetic neuropathy, AD and PD, with promising preclinical and clinical data [30,465,466,467,468].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“GM-based biomarkers have recently been considered as promising early and prodromal diagnostic tools in various neurological diseases, such as multiple sclerosis, AD and PD itself [30,156,157]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Grammatikopoulou, M. G., Goulis, D. G., Gkiouras, K., Theodoridis, X., Gkouskou, K. K., Evangeliou, A., Dardiotis, E., & Bogdanos, D. P. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa073 · Cited by 75
Liu, G., Ren, L., Song, Z., Wang, C., & Sun, B. (2014) · Food Control · doi:10.1016/j.foodcont.2014.10.049 · Cited by 74
Varesi, A., Deumer, U.-S., Ananth, S. V., & Ricevuti, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215077 · Cited by 73
Self-citationKosti, R. I., Kasdagli, M., Kyrozis, A., Orsini, N., Λάγιου, Π., Taiganidou, F., & Naska, A. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab078 · Cited by 72
Microbiota modulation by eating patterns and diet composition: impact on food intake
Klingbeil, E., & de La Serre, C. B. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00037.2018 · Cited by 71
Carter, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/501862 · Cited by 69
Targeting the Microbiota in Pharmacology of Psychiatric Disorders
Pascale, A., Marchesi, N., Govoni, S., & Barbieri, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104856 · Cited by 67 · cited 1×
“This relationship is therefore of outmost importance for the maintenance of gut homeostasis, and it has been reported to be also involved in the etiology of several metabolic and mental (psychiatric and neurological) dysfunctions and disorders [21,25].”
BackgroundSelf-citationBarbaresko, J., Lellmann, A. W., Schmidt, A., Lehmann, A., Amini, A. M., Egert, S., Schlesinger, S., & Nöthlings, U. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa053 · Cited by 67
Vitamins in Alzheimer’s Disease—Review of the Latest Reports
Mielech, A., Puścion-Jakubik, A., Markiewicz-Żukowska, R., & Socha, K. (2020) · Nutrients · doi:10.3390/nu12113458 · Cited by 65
Kaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 64 · cited 1×
“This relationship is therefore of outmost importance for the maintenance of gut homeostasis, and it has been reported to be also involved in the etiology of several metabolic and mental (psychiatric and neurological) dysfunctions and disorders [21,25].”
BackgroundPrinelli, F., Fratiglioni, L., Kalpouzos, G., Musicco, M., Adorni, F., Johansson, I., Marseglia, A., & Xu, W. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.05.066 · Cited by 63
Zhang, H., Hardie, L. J., Bawajeeh, A. O., & Cade, J. E. (2020) · Nutrients · doi:10.3390/nu12051528 · Cited by 61
Limongi, F., Siviero, P., Bozanic, A., Noale, M., Veronese, N., & Maggi, S. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.08.020 · Cited by 61
Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect
Gotkine, M., Kviatcovsky, D., & Elinav, E. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1767464 · Cited by 59
Ketogenic diet and cognition in neurological diseases: a systematic review
Pavon, S. E. D. C., Lázaro, E., Martínez, Ó., Amayra, I., Paz, J. F. L., Caballero, P., Al-Rashaida, M. A. H., Luna, P. M., García, M., Pérez, M., et al. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa113 · Cited by 59
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Zhu, F., Li, C., Chu, F., Tian, X., & Zhu, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.544235 · Cited by 57
Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative DiseasesPreprint
Gerhardt, S., & Mohajeri, M. H. (2018) · Preprints.org · doi:10.20944/preprints201804.0370.v1 · Cited by 56
Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Lam, V., Dhaliwal, S. S., & Mamo, J. C. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12032 · Cited by 55
A Critical Review of the Study of Neuroprotective Diets to Reduce Cognitive Decline
Duplantier, S. C., & Gardner, C. D. (2021) · Nutrients · doi:10.3390/nu13072264 · Cited by 55
Rationale and Design of the Emory Healthy Aging and Emory Healthy Brain Studies
Goetz, M., Hanfelt, J., John, S. E., Bergquist, S. H., Loring, D. W., Quyyumi, A. A., Clifford, G. D., Vaccarino, V., Goldstein, F. C., nd, T. M. J., et al. (2019) · Neuroepidemiology · doi:10.1159/000501856 · Cited by 53
Relationship between Wine Consumption, Diet and Microbiome Modulation in Alzheimer’s Disease
Moreno-Arribas, M. V., Bartolomé, B., Peñalvo, J. L., Pérez‐Matute, P., & Motilva, M. (2020) · Nutrients · doi:10.3390/nu12103082 · Cited by 53
Dyke, K. V. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90031-1 · Cited by 52
Bello-Medina, P. C., Hernández-Quiroz, F., Pérez-Morales, M., González-Franco, D. A., Cruz-Pauseno, G., García-Mena, J., Díaz-Cintra, S. Y., & Pacheco‐López, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.595583 · Cited by 51 · cited 2×
“, glutamate, hypoxanthine, thymine, hexanoyl-CoA, and leukotrienes) have also been considered in the same studies, showing promising results [106,107].”
BackgroundUse of ketogenic diets in the treatment of central nervous system diseases: a systematic review
Christensen, M. G., Damsgaard, J., & Fink‐Jensen, A. (2020) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2020.1795924 · Cited by 50
Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach
Rajanala, K., Kumar, N., & Chamallamudi, M. R. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666201215142520 · Cited by 36
Yan, Y., Gao, Y., Fang, Q., Zhang, N., Kumar, G., Yan, H., Song, L., Li, J., Zhang, Y., Sun, J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755164 · Cited by 36 · cited 3×
“Journal Study Cohort andDesign Analysis Performed Results Biomarker/s Proposed Yan et al., 2021 [106] Front.”
BackgroundKetogenic diet therapy in Alzheimer's disease: an updated review
Lilamand, M., Mouton‐Liger, F., & Paquet, C. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000759 · Cited by 35
Zhang, Z., Tan, X., Sun, X., Wei, J., Li, Q. X., & Wu, Z. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab328 · Cited by 35
Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease
Gaamouch, F. E., Liu, K., Lin, H., Wu, C., & Wang, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105046 · Cited by 34
Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice
Valeri, F., Guilherme, M. D. S., He, F., Stoye, N. M., Schwiertz, A., & Endres, K. (2021) · Microorganisms · doi:10.3390/microorganisms9122548 · Cited by 34
Deng, S., Chen, C., Lin, H., & Cheng, I. H.-J. (2021) · IUBMB Life · doi:10.1002/iub.2589 · Cited by 34
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33
Dietary Interventions to Prevent or Delay Alzheimer’s Disease: What the Evidence Shows
Bartochowski, Z., Conway, J., Wallach, Y., Chakkamparambil, B., Alakkassery, S., & Grossberg, G. T. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00333-1 · Cited by 32
Puścion‐Jakubik, A., Mielech, A., Abramiuk, D., Iwaniuk, M., Grabia, M., Bielecka, J., Markiewicz‐Żukowska, R., & Socha, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.738549 · Cited by 31
Moreira, S. C., Jansen, A. K., & Silva, F. M. (2020) · Dementia & Neuropsychologia · doi:10.1590/1980-57642020dn14-030008 · Cited by 29
Olsen, I., & Singhrao, S. K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110393 · Cited by 29
Dietary phytochemicals that influence gut microbiota: Roles and actions as anti-Alzheimer agents
Wang, Y., Lim, Y. Y., He, Z., Wong, W., & Lai, W. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1882381 · Cited by 26 · cited 1×
“…fresh fecal solution once daily for 4 weeks) ↑ Cognitive function (MWM and ORT tests) ↓ Amyloid β brain deposition (Aβ40 and Aβ42) ↓ Tau protein phosphorylation ↑ Synaptic plasticity (increased PSD-95 and synapsin I) ↓ COX2 and CD11b ↑ SCFA and microbiota composition Wang et al., 2021 [233] Brain.”
BackgroundGu, Y., Nishikawa, M., Brickman, A. M., Manly, J. J., Schupf, N., & Mayeux, R. P. (2021) · Current Alzheimer Research · doi:10.2174/1567205019666211222115142 · Cited by 25
Fecal microbiota transfer for bowel disorders: efficacy or hype?
Schmulson, M. J., & Bashashati, M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.08.012 · Cited by 24
Role of the gut microbiome in Alzheimer’s disease
Chok, K. C., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0122 · Cited by 23
Dietary interventions and cognition: A systematic review of clinical trials
Gkotzamanis, V., & Panagiotakos, D. B. (2020) · Psychiatriki · doi:10.22365/jpsych.2020.313.248 · Cited by 19
Alzheimer's disease clinical trials: past failures and future opportunities
Yaari, R., & Hake, A. M. (2015) · Clinical Investigation · doi:10.4155/cli.14.127 · Cited by 17
A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease
Bouftas, M. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.57 · Cited by 17
On the Possible Relevance of Bottom-up Pathways in the Pathogenesis of Alzheimer’s Disease
Leblhuber, F., Steiner, K., Geisler, S., Fuchs, D., & Gostner, J. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200514090359 · Cited by 16 · cited 1×
“A growing body of evidence indicates that gut microbiota dysfunctions are involved in the early disease stages of AD pathogenesis, enhancing immuno-senescence, oxidative stress, cytokine secretion, and neuroinflammation [79].”
BackgroundSalivary Aβ Secretion and Altered Oral Microbiome in Mouse Models of AD
Floden, A. M., Sohrabi, M., Nookala, S., Cao, J., & Combs, C. K. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210119151952 · Cited by 15
Haider, S., Schwarzinger, A., Štefanac, S., Soysal, P., Smith, L., Veronese, N., Dorner, T. E., & Grabovac, I. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5407 · Cited by 13
Włodarek, D. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000752 · Cited by 11
A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer’s DiseasePreprint
Bouftas, M. (2019) · Research Square · doi:10.21203/rs.2.17674/v1 · Cited by 3
Cited by
Communication of gut microbiota and brain via immune and neuroendocrine signaling
Kasarello, K., Cudnoch-Jedrzejewska, A., & Czarzasta, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1118529 · Cited by 247
“Moreover, numerous studies indicate a wellchosen diet as a quick way to modify the composition and metabolism of the gut microbiota, reduce inflammation, and help maintain eubiosis and proper dependencies in the gut-brain axis (Metta et al., 2022; Varesi et al., 2022).”
BackgroundResultUpdates in Alzheimer's disease: from basic research to diagnosis and therapies
Liu, E., Zhang, Y., & Wang, J.-Z. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 199
“The human gut harbors bacteria, viruses, and fungi [138].”
BackgroundAn Explainable AI Paradigm for Alzheimer’s Diagnosis Using Deep Transfer Learning
Mahmud, T., Barua, K., Habiba, S. U., Sharmen, N., Hossain, M. S., & Andersson, K. (2024) · Diagnostics · doi:10.3390/diagnostics14030345 · Cited by 167
“For feature extraction, by leveraging its ability to capture high-level features from input images, such as edges, textures, and shapes, we used EfficientNet as a feature extractor [1], where we realized a 6400 × 1280 feature matrix [33].”
MethodBlood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 139
“Though data are still inconclusive, gut bacteria family and genus shifts might represent promising tools as novel biomarkers for the diagnosis and progression of AD, and the restoration of gut microbiota balance a potential therapeutic approach [380].”
BackgroundSelf-citationBicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
“There is also some evidence that MCI and early-stage AD already show signs of pro-inflammatory bacteria increases, such as Escherichia/Shigella , in addition to increased inflammation [68].”
Metadata
- Authors
- Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., & Pascale, A.
- Affiliations
- University of Pavia (IT)
- University of Lancashire (GB)
- Université Libre de Bruxelles (BE)
- Policlinico San Matteo Fondazione (IT)
- Council for Nutritional and Environmental Medicine (NO)
- University of Verona (IT)
- Corresponding author
- Varesi, Angelica
- Ricevuti, Giovanni
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-02-05
- Volume
- 14
- Issue
- 3
- Pages
- 668
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8840394
- OpenAlex
- W4210475085
- Cited by
- 225
- References
- 248
- Citations by year
- 2026: 24 · 2025: 54 · 2024: 68 · 2023: 53 · 2022: 26
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion, other-oa)
- Funders
- Università degli Studi di Pavia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- gut microbiota, Alzheimer's disease, gut-brain axis, dysbiosis, neurodegeneration, microbiota-based therapy, prebiotics, probiotics, fecal microbiota transplantation, diet, early diagnosis, disease progression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Alzheimer Disease, Humans, Prebiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.